Fuanglada Tongprasert

Dr. Fuanglada Tongprasert


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2015 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
PSP. Sirikunalai
P. Sirikunalai
CWC. Wanapirak
C. Wanapirak
SSS. Sirichotiyakul
S. Sirichotiyakul
FTFuanglada Tongprasert
Fuanglada Tongprasert
KSK. Srisupundit
K. Srisupundit
TTTheera Tongsong
Theera Tongsong
The objective was to determine the strength of relationship between maternal free beta human chorionic gonadotropin (β-hCG) concentrations and rates of adverse pregnancy outcomes. Consecutive records of the database of our Down screening project were assessed for free β-hCG levels and pregnancy outcomes. Pregnancies with foetal chromosomal or structural anomalies and those with underlying disease were excluded. Free β-hCG levels of < 0.5, > 0.5 and < 2.0, and ≥ 2.0 MoM were categorised as low, normal and high, respectively. Of 17,082 screened women, 13,620 were available for analysis. In the first trimester (n = 8150), low β-hCG levels significantly increased risk for intrauterine growth restriction (IUGR), preterm birth, low birth weight (LBW) and low Apgar score with relative risk of 1.66, 1.43, 1.83 and 2.89; whereas high β-hCG group had a significant decreased risk of preterm birth and GDM with relative risk of 0.73 and 0.62. In the second trimester (n = 5470), both low and high β-hCG groups had significant increased risks of the most common adverse outcomes, i.e. spontaneous abortion, IUGR and preterm birth. In conclusion, abnormally low (< 0.5MoM) or high (> 2.0 MoM) free β-hCG levels are generally associated with an increased risk of adverse pregnancy outcomes. Nevertheless, high free β-hCG levels in the first trimester may possibly decrease risk of preterm delivery and GDM.

8 February 2011 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
SLSuchaya Luewan
Suchaya Luewan
YYY. Yanase
Y. Yanase
FTFuanglada Tongprasert
Fuanglada Tongprasert
KSK. Srisupundit
K. Srisupundit
TTTheera Tongsong
Theera Tongsong
Objectives: To establish normative reference ranges of fetal cardiac dimensions derived from volume datasets acquired using spatiotemporal image correlation with M‐mode display (cardio‐STIC‐M).Methods: A cross‐sectional study was undertaken on singleton pregnancies with normal fetuses and accurate gestational ages. Cardio‐STIC volume datasets were acquired by experienced operators using a high‐resolution ultrasound machine; these were maneuvered to obtain a four chamber‐view with exactly horizontal interventricular septum (IVS). Cardiac dimensions were measured in STIC‐M‐mode using 4D View software.Results: A total of 657 measurements, at a rate of between 15 and 37 per week, were obtained. Normal reference ranges for biventricular outer diameter, left and right ventricular inner diameter, left and right ventricular wall thickness, IVS thickness, left to right ventricular diameter ratio and left and right ventricular shortening fractions were constructed based on best‐fit equations as a function of gestational age, fetal head circumference and biparietal diameter. Thirty‐four volume datasets of abnormal fetal hearts were also separately assessed, many of which showed abnormal cardiac dimensions.Conclusions: This is the first report on normal ranges of fetal cardiac dimensions constructed using the new cardio‐STIC‐M technology. Preliminary evaluation suggests that these reference ranges may be a useful tool in the assessment of fetal cardiac abnormalities. Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.

1 December 2006 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
PCPIMLAK CHAROENKWAN
PIMLAK CHAROENKWAN
SSSupatra Sirichotiyakul
Supatra Sirichotiyakul
PCPharuhas Chanprapaph
Pharuhas Chanprapaph
FTFuanglada Tongprasert
Fuanglada Tongprasert
RTRawee Taweephol
Rawee Taweephol
TSTorpong Sanguansermsri
Torpong Sanguansermsri
Hemoglobin Constant Spring (Hb CS) is an unstable hemoglobin (Hb) variant that results from a nucleotide substitution at the termination codon of the alpha2-globin gene. The compound heterozygosity of alpha-thalassemia and Hb CS (--/alphaCSalpha) results in a Hb H/CS disease which is clinically more severe than deletional Hb H disease. Homozygosity of Hb CS (alphaCSalpha/alphaCSalpha) is generally characterized with mild hemolytic anemia, jaundice, and splenomegaly. The authors report 1 case with Hb CS homozygosity who presented with fetal anemia and hydrops. Intrauterine transfusions were given which rendered a favorable outcome. This report demonstrates an unusual and serious in utero complication in a fetus with Hb CS/CS.

12 November 2009 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
TTTheera Tongsong
Theera Tongsong
FTFuanglada Tongprasert
Fuanglada Tongprasert
KSKasemsri Srisupundit
Kasemsri Srisupundit
SLSuchaya Luewan
Suchaya Luewan

31 March 2013 in Prenatal Diagnosis
Verified
Journal Article
Closed access
TTTheera Tongsong
Theera Tongsong
PCPIMLAK CHAROENKWAN
PIMLAK CHAROENKWAN
PSPannee Sirivatanapa
Pannee Sirivatanapa
CWChanane Wanapirak
Chanane Wanapirak
WPWirawit Piyamongkol
Wirawit Piyamongkol
SPSavitree Pranpanus
Savitree Pranpanus

7 June 2016 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
TTTheera Tongsong
Theera Tongsong
SLSuchaya Luewan
Suchaya Luewan
PJPhudit Jatavan
Phudit Jatavan
FTFuanglada Tongprasert
Fuanglada Tongprasert
KSKornkanok Sukpan
Kornkanok Sukpan